Bridgepoint Group plc (BPT) Earnings Call Transcript
March 13, 2025
Earnings Call Speaker Segments
Good day, everyone, and welcome to Bridgepoint Group's 2024 full year results. We'll begin the presentation shortly. Once it's done, there will be a Q&A session. Should you want to pose a question, you can do so through the Zoom webinar link that was provided separately, or by sending a written question via the Ask a Question button on the Spark Live webcast page. For those of you who joined through the Zoom webinar, please be aware that this call is being live streamed to a webcast for a large audience and is being recorded. During the Q&A part of this morning's call, if you'd like to ask something, please use the raise hand function at the bottom of your Zoom screen. If you already have a question in mind, please do that now, so you're ready for when Q&A starts. I'd now like to hand the call over to Raoul Hughes, CEO, to open the presentation.
Morning, everyone, and welcome to Bridgepoint's 2024 full year results. I'm Raoul, Bridgepoint's Chief Executive, and I'm delighted that Ruth Prior, our CFO, is here with me in the room this morning. I'll begin today with a high-level snapshot of how we've performed, then go into somewhat more detail on the broader positioning of our business. After that, Ruth will take you through our financial performance and revised guidance in detail before we open things up to Q&A. My expectation is that we'll probably be talking for around half an hour. I thought I'd start with a key message for you to take away today. Bridgepoint continues to perform strongly, and we are increasingly confident in the outlook for 2025, and perhaps more importantly, in carrying this into the longer term. We are a more diversified and scaled group following the closing of the ECP transaction, with a correspondingly higher quality of earnings. Importantly, over the next few years we expect to make further progress on our diversification journey as part of our medium-term strategy to grow to $200 billion of AUM. I'll say more about this a bit later, but first, let me turn directly to performance. In 2024, we maintained our deployment pace while retaining necessary investment discipline, with our funds continuing to perform across the board.
We handed back a record sum of capital—roughly EUR 8.5 billion—to the investors in our funds, which is quite an achievement considering how the broader market has been trending. We've moved substantially closer to our fundraising goal of EUR 20 billion by the close of 2026. That's precisely why we are today lifting that expectation to EUR 24 billion. Toward that aim, our SMID cap private equity strategy will soon wrap up BDC5 at its hard cap of EUR 2.8 billion, versus a cover number of EUR 2 billion. That may be more of a knockout showing than a fresh trend one can extrapolate from, yet it is an impressive display all the same of how much interest investors have in the Bridgepoint brand. All told, we find ourselves in a position where the core engines of long-term value are firmly in place, and that has left us more confident regarding our ambitions for growth. Now to more detail on how we performed. As in earlier presentations, we are displaying our 2024 numbers, which include a full 12-month contribution from ECP. For clarity, we've helpfully colored it blue. Both our private equity and credit businesses keep expanding and delivering strong results. Naturally, bringing ECP in drove a step change in scale relative to 2023. AUM rose 4% organically and jumped 69% once ECP is included. Management fee and other income climbed 14%, on the back of successful flagship fundraisers for Bridgepoint Europe and ECP, along with more invested capital in credit.
FRE rose 16%. EBITDA went up 7% organically, and once ECP is included, it nearly doubled to GBP 292 million. Now, I'm very happy to report that even though 2024 consensus EBITDA climbed 19% over the course of last year, every one of these metrics also exceeds the current consensus by additional single-digit percentages. AUM by 9%, and importantly, FRE and EBITDA by 5% and 3%, respectively. Those are the headline financials, but what matters perhaps even more looking ahead is that the enlarged group is more diversified now. This holds for both the type and the geographic location of fund investors, and it holds as well for the diversity of investment strategies across vertical and geography. Excitingly, there's more still to come. A further increase in sovereign wealth capital and, indeed, private wealth, or the expansion of geographies where our verticals operate, on either side of the Atlantic and perhaps further east too. On fundraising, 2024 proved a strong year, with two flagships completed and a very successful fundraise for BDC. Altogether, we raised EUR 8 billion, with EUR 6 billion counting toward the new increased target announced today of raising EUR 24 billion for next cycle funds by the end of 2026.
BDC5 stood out because it was raised swiftly in a tough market and started paying fees during the latter half of 2024. BDL4 has now held an initial close at 50% of the cover number, and we’ve likewise closed our sixth and seventh, and as of last week, our eighth CLO has been priced, taking total CLO AUM past EUR 3 billion. This year, fundraising has kicked off for ECP’s next flagship fund, and we will also be raising a core plus evergreen product that will at first draw institution and capital. In fact, a EUR 1 billion anchor investor committed to join this week before going on to enter the wealth channel. On the credit side, we’ll keep fundraising for BDL4, begin raising and investing BCO5, and anticipate pricing no fewer than one additional CLO. Broadening capital sources past the institutional LP investor base represents a key opportunity, and we expect to hold an initial launch of our wealth product, to be named Generations, during the first half of this year. As a reminder, this will be an open-ended evergreen private equity vehicle delivering our flagship strategies to individual investors. On the distribution side, our focus will be on the established and regulated banks.
That covers the global wealth platforms along with the private banks that are more regionally focused. We think we can get to scale in an effective way, make use of the IR team we already have, and make sure our brand sits next to partners who are equally trusted. Then, in 2026 — next year — BE8 is expected to start being fee-paying from the middle of the year, with fundraising anticipated to wrap up in 2027, and we'll also raise another two CLOs on top of that. I'd like to go on and take a moment to talk about strategy. Our target over the medium term is to get to roughly $200 billion of AUM, growing organically and via M&A, across the coming five to six years. You've certainly heard me say this before: I do feel that AUM is somewhat of a lazy proxy, and my focus — as is Ruth's too — is on growing revenues and profits. In fact, I don't believe all AUM is equal. As a value-added alternative assets manager, I would hope that each dollar of our AUM generates higher fees than is the case for some of our competitors. As we pursue growth, there are three things we'll be aiming to achieve. First, we expect our existing footprint to keep growing as we work diligently and incrementally to build up the size of our current series of funds, making sure we raise the right amount of capital for every product in every cycle, and also by diversifying the funds we offer within existing investment strategies, building on our strong positions in private equity, credit, and infrastructure.
Like I mentioned back at the CMD in October, we're confident this can generate roughly $50 billion in AUM growth. Next, we intend to speed that up through focused bolt-on M&A that complements what we do, along with team lifts. Those moves will target spaces where we can add further know-how and exposure. Examples of that kind of expansion could include new products in credit and sector-specific expertise within private equity. Third, we aim to keep growing the business via platform-enhancing acquisitions. Bridgepoint Credit and ECP have both worked well, been integrated properly, and added meaningfully to the group. We'll consider similarly transformative M&A going forward. Through acquisitions we can enter new asset classes and geographies at scale, strengthen our market position with more AUM, broaden the diversity of our income stream, and bring extra expertise plus new investors onto the platform. That would speed up growth for the group and open opportunities to create material value for shareholders. Those opportunities might sit in additional verticals such as real estate and/or new geographies where our current verticals have a smaller presence, whether that's Asia, Europe, or indeed the United States. Such deals are, though, binary and obviously culture-dependent, but I'd be confident that across a five- to six-year period, Bridgepoint can deliver circa $50 billion of AUM growth in this way while materially improving the quality of our earnings.
Alright, let me now walk you through a few slides covering each of our three existing verticals, so you can see why we believe all of them sit in genuinely strong positions in their respective markets. With all the current enthusiasm around anything electricity-related, I'll begin with added value infrastructure. ECP holds a strong position in both electricity and sustainability. There has been plenty of discussion about AI and what it means for electricity demand, but beyond that, the US electricity investment market stands to gain from the new generation capacity required to replace coal-fired plants and aging nuclear facilities, along with demand growth stemming from manufacturing reshoring, transportation electrification, crypto market development, and, clearly, the building of AI data centers. Our strategic partnership with KKR aimed at data center investment amounts to a strong endorsement of ECP's expertise in a complicated, regulated market, where handling the permitting and grid connections necessary to bring new generation online for AI data centers is a valuable skill set that is very rarely found. I'd also like to spend a moment on Calpine, which illustrates how ECP can buy well, optimize operations, and then sell well.
Strictly speaking, this isn't a 2024 event, and it still needs regulatory approvals, but the sale to Constellation Energy is a strong illustration of the type of deal ECP handles very well. Back in 2017 it was ECP's biggest investment ever, and it will become our biggest exit ever, and in fact one of the biggest exits our industry has ever seen. When the deal closes, consideration will be divided between cash and Constellation shares, so we keep exposure to the U.S. electricity generation sector until those shares are sold. Announcing the sale now has the extra advantage of delivering meaningful returns to fund investors before the ECP 6 fundraising, which is always a positive. Now, moving to our credit business, we have ongoing momentum in a key fundraising year for the strategy across direct lending, credit opportunities, and CLOs. BDL3 keeps performing well, with direct lending net leverage currently at 5.8 times EBITDA. Importantly, by keeping good interest cover at 1.9 times and low loan-to-value at 35%, there is ample cash and equity value buffer if needed. The portfolio is well diversified across our target sectors and geography, which together means we have a low level of what we call watchlist credits, and fingers crossed, I expect to keep reporting that the strategy has zero realized losses going forward.
Let me also briefly touch on the CLO business, which has proven a genuine success story for the firm. We started that strategy organically back in 2020, and we keep issuing two CLOs per year — the latest one being CLO8, which, as I mentioned, priced last week. I'd also like to call out a rather impressive event from earlier this year that further showcased how well the strategy is working: the upsizing and refinancing of CLO4. Its size grew from EUR 320 million to EUR 450 million, supported by robust demand from both new and existing investors. On top of that, the reinvestment period was pushed out to 2029, and the cost of capital came down to market-leading levels — clear evidence of the portfolio's low risk and, I would say, the manager's quality. That means we can collect fees for a longer stretch, and our equity return gets a boost. Finally, on private equity, it's worth recapping how we generate returns there: by combining asset selection — picking businesses that satisfy our gatekeeping criteria — with value creation during the time we own them. Beyond concentrating on particular niches, we seek out European companies that offer high revenue visibility, high EBITDA margins, and strong cash conversion.
Next, we aim to generate value by combining several approaches: pushing international growth—taking a national champion and extending it across Europe and/or into the U.S. to build additional global revenue streams; buy-and-build programs, particularly in fragmented markets; and assisting companies in advancing to the next level of operational excellence, or occasionally repositioning a business to capture new opportunities. Having acquired well and added value, we can then sell well, frequently to U.S. businesses, and produce attractive returns for our investors. Speaking of the U.S., tariffs have been discussed a great deal lately. As you would expect, we have analyzed how tariffs might affect our equity portfolio, and I'm pleased to say that we'd expect any impact to be relatively limited given the general structure of our portfolio operations in the United States. The United States is a significant end market for us, but our portfolio sales generally don't come from imports, and our portfolio companies with the most materials sales—the two of them really, Meristem, which is in Agtech, and Balt in Medtech—both have domestic U.S. production facilities. We are stock pickers rather than macro market investors. We continue to benefit from investing in select niches within high-growth sectors in Europe.
Although Europe's GDP has trailed that of other regions for a great many years, overall market growth across the four sectors we've selected runs well above European GDP growth, coming in somewhere between 6% and 11%. Within each of those sectors, the particular niches we put money into are growing faster yet — somewhere in the 12%-38% range, averaging in the low 20%. Those growing niches are what underpin the returns we managed to deliver in the middle market, as the realized returns for each sector show. Now, a case study. Vitamin Well is an excellent illustration of how we generate value. Our initial investment came in 2016, after an off-market process run by our BDC team in Stockholm, and it was reinvested through our flagship in 2021. The company began as a successful functional food and beverage business in the Nordic region. The capital we put in over the last eight years funded geographic expansion across Europe and then into the U.S., which grew to represent roughly 30% of group revenues last year. We also backed new product development and category expansion to enlarge the addressable market. Finally, we strengthened the management team considerably and helped put in place new structures, systems, and processes to support and sustain the company's growth.
From the time of our initial investment, revenue at the business has grown 14-fold. As the slide shows, after we sold a controlling stake last year, we were able to return an exceptional amount of capital to our investors. Taken together, ECP stands as a top investor in North America spanning energy transition, electrification, and decarbonization, and those sectors still hold meaningful tailwinds after the change in administration in the United States. On the credit side, we have a robust European platform, our portfolio metrics are still favorable, and our funds continue to track toward delivering target returns for fund investors. Our private equity business sits in a sought-after segment of the market because we invest in growing middle market companies within select niches, and those companies have a record of consistently strong performance through cycles. With that, I'll turn things over to Ruth.
Good morning. I'll walk you through how we performed financially in 2024, and after that I'll bring you up to date on our guidance for 2025. I'll go over underlying results for the group as a whole, on the assumption that ECP had been part of the group for 12 months, and I'll also show you the organic performance of the business without ECP included. Taking into account both organic growth and the contribution from ECP, EBITDA nearly doubled in 2024, rising by 96%, while EBITDA margin went up by 8% points to 54%, the first time it has gone above 50%. That is a strong indicator of the group's growing strength and trajectory. Successful fundraising from the previous cycle has locked in near-term FRE and driven organic FRE growth of 16%. After a year of record capital returns to fund investors across all strategies, we are upgrading our guidance for fundraising in the current cycle and now expect to raise EUR 24 billion starting from mid-2024 to the end of 2026. To sum up 2024: the combination with ECP has increased our scale and diversification and increased our quality of earnings. Together with our strength across deployments, exits, and fund performance, that gives us confidence to increase our fundraising guidance.
Our assets under management are now $75.6 billion. During the past 12 months, we brought in EUR 5.7 billion in total across BE7, BDC5, BDL3, Credit Opportunities 4, and CLO6 and CLO7, and we also delivered EUR 4.6 billion in divestments. Valuation gains across our funds contributed another EUR 3.2 billion. As a result, with ECP included, AUM ended 80% higher than the prior year — and note that the gap between the dollar growth percentage and the euro growth percentage comes from FX. Now looking at fee-paying AUM, over the last year we raised EUR 3.4 billion and put EUR 2.3 billion of new fee-paying capital to work across our credit strategies. Offset against that, fee-paying assets fell by EUR 3.6 billion due to investment sales and capital returned. Once more, counting ECP's EUR 10.6 billion of fee-paying capital, fee-paying AUM rose 49% to EUR 38.7 billion. Placing our 2024 performance within our longer-term track record reveals steady improvement, with an EBITDA CAGR of 38% since 2018. The EBITDA margin has climbed from 30%-54%, putting us well on track to hit the 55%-60% target we set at last year's CMD. A strong and compelling stretch of a few years that we will keep building on.
Now turning to the details of 2024 deployment, exits, and fund performance. Last year we saw robust deployment right across every investment strategy. BE7 has put 64% of its capital to work through 13 investments. Of those, 11 came through off-market or bilateral processes, leveraging our sector teams and local offices to source and convert opportunities. Among the recent investments are Esker, a top global supplier of AI-driven automation solutions for the office of the CFO, headquartered in Lyon; Schuberg Philis, which provides managed IT services for mission-critical applications at large organizations, based in the Netherlands; and Samy Alliance, a social-first digital marketing group headquartered in Madrid. Having taken a minority stake in 2023, we now hold a majority shareholding. BDC5 is already 11% deployed, after acquiring two platform companies through the take-private of ECHO, a global provider of customer engagement data security solutions, and Argon, a global consultancy specializing in industrialization and supply chain excellence. On the infrastructure side, ECP5 stands at 66% deployed, and ECP6 should begin paying fees in mid-2025, once ECP5 passes 75% deployed. Bridgepoint Credit has kept up its strong pace, deploying EUR 1.9 billion across direct lending, credit opportunities, and CLOs. Finally, with BDL3 now 88% committed, we have begun fundraising for BDL4.
Beyond solid deployment, we’ve also done a good job returning money to investors. For capital returns, 2024 stood out as a record year—even stronger than 2019 and 2022, which had been the prior peaks. Private equity and credit together gave back EUR 4.7 billion to fund investors, and ECP returned EUR 3.8 billion, amounting to EUR 8.5 billion in total. Those sizable capital distributions plainly leave us in a strong position as we begin the next fundraising cycle in BE and ECP. Among the year’s notable exits were Kyriba, Care UK, Vitamin Well, and Oris Dental, along with the agreement to exit Calpine, which will keep paying dividends until the exit is complete. Just to flag, the Dorner and Calpine transactions are still awaiting regulatory approval and aren’t reflected in these figures. Dorner would contribute another EUR 1 billion, and Calpine would add $1.4 billion. With the first quarter now behind us, we have solid visibility into the 2025 exit pipeline. In the end, fund performance is what underpins our business model. Across all three of our verticals, the funds keep delivering strong results. Every one of our flagship funds ranks in the top quartile on a range of measures. The valuation gains in our funds came from trading activity, with 83% of unrealized valuation multiples either unchanged or lower during that period—which really highlights how strong the earnings performance is within our portfolio.
On the valuation side, it's also worth keeping in mind that a 35% uplift in value has historically been realized at an actual exit, and during 2024 the values realized came in 29% above the most recent fund valuations. As Raoul has laid out, we're in a strong position to carry that performance forward into 2025. Our management fees are steady. Those revenues are contracted and locked in, and the average fee across our current portfolio sits at 1.17%, charged on funds whose average life exceeds nine years. At present, we have visibility into roughly 85% of fee income for 2025 coming from funds we have already raised. Management fees and other income combined grew 14% organically, and 52% year on year once ECP is included. I've just covered exits, record capital returns, and strong fund performance, and all of that fed through into a 150% rise in PRE. That said, organic PRE slipped modestly year on year, because certain transactions agreed in 2024 had not closed by year-end. At 26%, PRE as a share of total income came in slightly ahead of our guidance of circa 25%. Going forward, a material increase in PRE is on the way across the next cycle, driven by a rising share of carry flowing to the PLC and a larger quantum of co-investment in our newer funds.
For BE6, house carry comes to 7%, while BE7 sits at 23%. Since fund sizes are growing, what you get is a bigger percentage applied to a bigger number. Those charts illustrate that from 2018 through 2024, we put GBP 0.7 billion into co-investment across the funds shown, booked GBP 0.4 billion of gains in the P&L, and collected GBP 0.6 billion in cash distributions. Looking ahead from this year to 2031, if the funds we have already raised — the ones listed on the right-hand side — hit their target returns, the comparable numbers would be another GBP 0.2 billion of co-investment, an additional GBP 1.2 billion recognized in the P&L, and a further GBP 1.8 billion of cash received, on top of what has already come in. Turning to capital allocation, for us it is fairly straightforward. To repeat what we laid out at the CMD: we back organic growth, we co-invest in funds, M&A remains on the agenda, and then there are capital distributions. On the right-hand chart, you can see how our progressive dividend policy has delivered a rising dividend per share annually. The table underneath shows the total capital returned to shareholders through dividends and through share buybacks in 2023 and 2024.
As the existing program wraps up at month’s end, we aren’t planning to prolong it. At this point, in our view, the trade-off for that capital—strong growth opportunities versus buybacks—has tilted back toward the growth side. Lastly, I’ll walk you through guidance, including the raised outlook for fundraising. A year ago, we said EUR 20 billion in funds would be collected by the close of 2026 for the next cycle funds. As of today, we’ve lifted that figure, and we now expect to bring in EUR 24 billion by the end of 2026. That will be divided approximately equally across strategies, though possibly somewhat lower in credit than in private equity and infrastructure. Although we anticipate BE8 turning fee-paying in mid-2026, fundraising for it is expected to carry on through 2027, meaning the entire sum won’t be included in the EUR 24 billion target. To underpin that expansion, ongoing spending on the platform capabilities required for growth will cause expenses to rise at a high single-digit % annually. We still anticipate PRE accounting for circa 25% of total income throughout 2025 and 2026. This comes down to timing, and some exits could land in Q4 of this year or Q1 of next year—notably Calpine—along with when carry for BE6 is recognized.
For 2025, just like in earlier years, our current expectation is that PRE will carry roughly two-thirds of its weighting toward the second half. Our EBITDA margin is expected to land between 52% and 55% across 2025 and 2026, and then rise to 55%-60%, matching industry peers, once AUM reaches EUR 200 billion. That said, I'll turn things back to Raoul ahead of Q&A.
Great. Thank you so much, Ruth. In closing, we've heard that following the ECP transaction's completion, we are a group that is more diversified and scaled. Bridgepoint Group turned in a really strong performance in 2024, posting financial results that came in ahead of what the market expected. Deployment and fund performance were both strong throughout the year, and importantly, we saw record capital returns ahead of the next fundraising cycle, which has let us raise our fundraising target today. We're confident about delivering on the organic and inorganic opportunities so as to realize our growth ambitions. All in all, we find ourselves in a position where every core driver of long-term value is positive, and we grow increasingly confident in our ability to increase AUM to over EUR 200 billion over the next few years. With that, I'll hand you back now to Sophie, who can walk you through how to ask questions. Thank you so much.
At this point, ladies and gentlemen, we'll move into the question-and-answer portion. Anyone can send in questions through the webcast page by hitting the Ask a Question button. Should you be on the call by dial-in and want to pose a question, kindly use the Raise Hand feature located at the bottom of your Zoom screen. For those joining by phone, raising your hand is done with Star nine, and pressing Star six will unmute you. We'll take a brief pause to put the queue together. Our first question comes from Angeliki Bairaktari of JPMorgan. Please go ahead.
Morning, and thanks for taking my questions. I have a few, please. First, on credit fee-paying AUM — that grew a bit more slowly than I had expected. Could you discuss the deployment and realization dynamics you're seeing in credit right now? Second question, thank you very much for the detail on the evergreen products, both the ECP product and the Bridgepoint product you plan to launch. Can you remind us what management fee margin you'll earn on this ECP evergreen and also on your evergreen? Last question on the EBITDA margin guidance, now at 52%-55% for 2025 to 2026. You still guide for high single-digit growth in expenses per annum. Consensus seems to assume around 6% higher costs and flattish revenues for 2025. I was wondering if you could give us some color. Is the upside for the margin expected to come from higher management fees or higher performance fees this year? Thank you.
Thanks a lot. Ruth, would you like to —
May I take the final question?
Could you start with the final question?
Angeliki, what's driving the EBITDA margin is improved FRE and PRE, and in fact we're guiding costs to high single-digit since investment in growth is necessary.
We'll take this in reverse order. For evergreen products, I'd say you're likely being fairly conservative in assuming roughly 100 basis points on average across the board. Some will — my guess is the generations will come in a bit higher, and I'd expect the core plus infrastructure evergreen to land somewhat lower. On the whole, that's a sensible proxy. I mean, these are new products for us, so this will develop as we build the capital within them. Credit, credit fee-paying AUM?
My guess is the consensus estimate likely fell a bit short of where it should have been, since in fact we believe credit is performing remarkably well right now, as you mentioned.
Yes. I mean, on credit — I think they’re putting sensible amounts of capital to work across the products, and as you’d expect, there is a — let’s step back. Looking at the broader market, credit deployment and redemptions really depend on market activity. Standing here in Q1 2025, our sense is that market activity is higher. From our equity standpoint, we’re certainly seeing more opportunities to put capital to work than was probably the case 18 months ago. I think there’s a feeling that the market is opening up somewhat. Is deal activity anywhere near the levels seen a few years ago? Not yet, no. I think that will show up in the character of the credit business.
Mind if I just add one more question? Sure, sure. Regarding those evergreen products, could you make clear whether fundraising of any kind is included within that $24 billion guidance for 2024 to 2026?
The evergreen in the ECP, yes, that is included. As for generations, no, it isn't.
All right. Regarding credit deployment and realizations, the reason I'm raising these questions is that over the past year the broadly syndicated loan market has actually been picking up some market share from direct lending players. I was wondering whether that's something you're seeing too, or whether in the middle market you're somewhat more insulated from this trend? It's not a noticeable trend that we've seen in our business and our deployment within our credit team — I wouldn't say so.
Thanks. Angeliki, we're really just one player in this market, and the only thing we focus on is where our origination platform is producing opportunities for us. Looking at it from a whole-market standpoint is pretty difficult.
That's quite clear. Thanks a lot.
Nicholas Herman from Citi has our next question. The line is yours.
Morning, Raoul. Hi, Ruth. Thanks for the update. I have three questions, please. Pardon me. First, does that fundraising guidance for the cycle take in the continuation fund and the SMA opportunities you mention, or do those sit on the upside? Okay. I suppose, are they specific to ECP, or do they also apply to private equity? Second, on the KKR partnership, at the CMD you clearly didn't want to put a number on that opportunity, since, as you said, it was quite difficult to quantify and the partnership hadn't been announced yet. That's completely understandable. I suppose, now that several months have passed to work through it, do you have clearer visibility into how that partnership might take shape going forward? Lastly, on ECP6, I believe you mentioned a cover number of $5 billion. That is, only in better comments, a 14% uplift versus Fund 5. As you build that fund and engage with investors, could you talk about appetite and, I suppose, what leads you to such a modest uplift given clearly strong strategy performance and strong exits like Calpine? Presumably, you'd see upside to that. I suppose, as part of that, when would you expect to have a view on the ability to set a hard cap?
Thanks.
Alright, let's try to address all three of those at once.
My impression is that they're joint.
I think all of these things kind of converge. Those three really are at the forefront. Let me start us off, and then Ruth will sort of jump in. The way we'd like folks to think about fundraising is that we've got a whole array of fundraising opportunities spanning the verticals and the products inside those verticals. We sit down and consider how much capital we're aiming to try and raise for different strategies at different points over the investment cycle. We look at the whole picture and think, well, some portion of that will come through, some portion won't, some portion will be pushed back, and some portion we'll need to pull forward. When you look at it in the round, what kind of number do we feel — well, the two of us ultimately, since we're sitting here, but the whole business — feel willing to state publicly is a number we're going to achieve? When you look at — when we ran that exercise, we felt that the opportunities to raise capital across the platform gave us real confidence in telling you guys today that 24 is a good number rather than the 20 we were guided to in the past, based upon where we feel we stand today.
If you attempt to split the 24, and as Ruth mentioned during her presentation, we generally view it as approximately even among the three verticals, though in practice the credit fundraisings and the size of our credit business compared with the others will likely be a bit below the other two. That's the kind of guidance we aim to provide regarding fundraising, rather than focusing on a specific figure in any particular fund—that's probably the right way to think about it. How do we feel as a team inside the business—are we confident telling you folks that we'll deliver for next generation funds within that timeframe? What we're defining now is capital we will raise for next generation funds across 2024, 2025, and 2026. At some point over probably the coming year, we'll extend that to 2027 and other timeframes. That's the kind of timeframe we mean, and it covers funds we raise for the current vintages. Those will either be the flagships and core funds in our spaces, or indeed SMAs and similar things alongside them. One thing I believe there's evidence of—particularly in the credit world, but I think it's arriving for infrastructure and private equity regardless—is that the old approach of simply raising a flagship fund and then raising another one is shifting, and people will be raising various types of funds that co-invest alongside one another through an investment sort of period.
I wouldn't get too—we're attempting to steer you away from being overly precise regarding where that capital lands, whether in a flagship fund, an SMA, or something alongside it, and instead to consider the whole picture. That figure is what we're projecting to raise over that stretch. If you consider the timing of the next flagship equity fund, BE8, our expectation, as we've stated, is that raising will likely begin after the summer. Pre-marketing has begun. Plenty of people are traveling the world having initial conversations with investors about appetites and thinking and so forth as we shape the strategy. We'll probably launch it after the summer. We'd expect it to enter fee-paying mode from around halfway through next year. The reality of a fundraising cycle is that we won't wrap up that fundraising until 2027. A portion of that fund will sit outside the $24 billion we're discussing today, since it won't be raised within the timeframe.
On your specific question about ECP—and I believe it concerned the KKR partnership, co-investment, and SMAs—at present we'd say the bulk of that isn't included in the $24 billion. As Raoul just described, we're taking a look at the overall picture. I'd say we're still evaluating the opportunities there, and we'll provide further guidance as we see fit during the year or into next year. Regarding ECP6, the cover number is five. Would you like to discuss cover numbers?
Yes. So the cover number is, clearly, whatever figure appears on the front of a PPM. Our terminology for it is a cover number, rather than what people may previously have read these figures as, which is targets. The reason is that the amount printed on the cover of a book isn't necessarily the target we set ourselves for raising. As we've consistently stated over time, what we always intend is to raise the appropriate amount of capital for a fund across a fund cycle. In the end, how much gets raised will hinge on — clearly, it will hinge on demand, but it also hinges on your sense of how effectively you believe you can put that capital to work during that stretch of time. A cover number, I wouldn't treat it — I'd ask that you not treat it as a firm, fixed view on our part regarding how much capital will be raised. It's simply a figure that happens to appear on the book.
BDC5, for instance, came in with a cover figure of two, and we've simply been wrapping that up at 2.8, just to offer one illustration. With the other funds, a cover number exists — that point where you determine you're going to halt. Yeah. I think if — yeah, if Doug were present, his take would be that this marks where the discussion begins, the ECP6.
Thanks. That helps a lot. On ECP6 specifically, like you mentioned, the cover figure isn't — it's sort of — it ought to be — apologies, the amount you ought to be increasing is sort of tied to how much you figure you're able to deploy. Obviously, ECP has stated it holds plenty of chances to deploy, which is likewise the reason it will be raising SMAs. How ought we to approach framing that, and then the division between SMAs and the fund?
To reiterate what I mentioned a moment ago, the SMAs along with the KKR partnership aren't included in that $24 billion figure. What it really consists of is the evergreen ECP6 plus a small amount of Coinvest. There's also a continuation. Plus a continuation fund. We'll begin providing more guidance on those other items at a later point.
Great. Thanks a lot.
The following question is from Duncan Farr at Jefferies. You may proceed. We have a question again from Duncan Farr of Jefferies. Kindly unmute your line and pose your question. All right, we'll return to Duncan later. Gregory Simpson from BNP Paribas has the next question.
Morning. Can you hear me okay? Yeah, yeah. Perfect. All right. Yeah, a few from my end. First, a meaningful part of the consideration for Calpine is in Constellation Energy shares, which have been quite volatile. Can you give some color on how Calpine is factored into the 25% PRE guidance sensitivity there? Second, on BE7, you deployed about a third of the fund last year, and it's about two-thirds invested today. I guess, would you see scope for the mid-2026 activation of BE8 to be conservative? Any kind of comments on the deployment outlook for BE? Okay. And then finally, just any comments on M&A? We have seen a bit of a pickup in deals in the industry this year. Is that still on the agenda for you? Thank you.
Would you like to start with the first one?
Yes. Calpine, the straightforward response is that Calpine will support PRE, our 25% guidance on PRE, really across the coming 2 to 3 years. That's the straightforward response. I'll provide you a bit more detail in that the group has exposure to Calpine through 2 funds, so ECP4 and the Calpine Continuation Fund, and the carry percentages, I believe, are 12% and 15% respectively. The deal was $4.5 billion of cash and the remainder in $50 million of shares of Constellation. Those shares can be sold June 26, 50%, and June 27, 50%. Clearly, it still has to secure regulatory approval, which we think might take as long as 12 months, which is why I was saying it's one of those items that could flip from Q4-Q1 quite easily. It's currently valued in our books, clearly, and our policy is to discount carry by about 30% until we're much closer to an exit. It's got some PRE impact in 2024. It'll have clearly some if we get regulatory approval in 2025. Clearly, if we sell shares in 2026 and 2027, it'll have some more. It will depend on the shares of Constellation, the share price of Constellation, which, as we know, have oscillated since the agreement from, I think it went up as far as $340 and down to $215.
Analysts covering Constellation see the stock landing somewhere in the $250 to $350 range. From our standpoint, the cleanest way to frame it for you is that it sits inside the 25% guidance, and when it comes to selling those shares, the timing is ours to choose.
There's perhaps one more point worth mentioning: in setting that 25% guidance, our assumptions regarding where the Constellation share price ends up in order to hit it have been fairly conservative. Yes. That's the right way to think about it. Those shares are going to sit within the ECP fund. A decision will be made by ECP after the lockups. I mean, the shares are highly liquid, but as an investment committee they'll decide when they feel the moment is right — since this is principally a fund investment in which we hold some exposure — to sell those shares, and that call will rest on their view of the future of electricity generation in the United States. To return to something we said earlier in the discussion, there's a great deal of optimism regarding where that US sector will keep heading. I'm not at all certain that the view ECP adopts will be to sell the shares the moment they unlock, the moment they're able to. We'll have to see. It's a very fair question, because unusually for a business such as ours — where you'd think of our investment activities as generally quite well diversified — and it's one of the characteristics, if you look at a typical Bridgepoint equity fund, that we're investing in 16 to 20 platform investments.
We generally aren't specifically exposed to any single exit or any single asset in Constellation's case, given how large the investment is, but above all because of the blowout returns and the sheer success of those returns. There's a concentration element around that one asset that's unusual for us. You're right to bring it up. BE7 — we keep repeating this. The point when BE7 moves into BE8 depends on how fast BE7 invests. We have a tremendous origination team across Europe that's constantly reviewing opportunities. Right now the pipeline in BE looks really good. It seems like there's a solid volume of opportunities the team is examining throughout Europe. We're stock pickers. We only buy what people are willing to sell us. It's binary, much like M&A, which I'll get to shortly. The capacity to keep investing is binary. If you go through a stretch of investing, winning a number of deals and deploying faster, it could be somewhat quicker than what we're saying, but I wouldn't want to bake that in.
For us, the key priority is locating the right deal, executing it properly, and investing in it extremely well. As a business, we care less about the marginal month in which it flips over. M&A — we devoted quite a bit of time in October to discussing M&A. My headline for today, I suppose, is that nothing material has shifted relative to where we laid this out in October. As I attempted to allude to earlier, the M&A we'll be pursuing falls into a couple of discrete buckets. First, there are the infill, smaller tuck-in opportunities inside the existing verticals. We see those constantly. A number of conversations are ongoing. Whether they lead to something or not, we'll see. Those are more modest individual transactions. Then there are more transformational M&A opportunities. As I said earlier, sitting here in March 25, I feel really confident that inside the five to six-year window we've set ourselves, opportunities for material M&A across the platform will arise. We believe we've got a great business. We believe we've got a really well-positioned business.
We believe it's also a highly appealing platform for other participants in the alternative space who would want to come and join us. As we've said repeatedly, we think the value-added, globally diversified middle-market platform we have is a genuinely interesting place for other alternative players to want to come and work. I'm fairly confident that at some point we'll deliver one or two transactions that will grow AUM by roughly the $50 billion we're discussing. Will that be 2025, 2026, or 2027? It hinges on binary outcomes. We're extremely selective. There are numerous conversations happening constantly. I devote a good deal of my time to speaking with many people across the world who are interested, or might become interested at some stage, in joining Bridgepoint. It's a continuing dialogue. All of them are fascinating dialogues and always worthwhile. It's about finding the right one. I'm confident we will. Which one and where it will be, we'll see. Ultimately, as we've also said before, it comes down to culture. There are many truly great firms that would fit neatly into this business.
We’re looking for a company at the right point in time whose culture feels very similar to how the business’s culture is today. In a sector that relies heavily on people and is dominated by people, we believe we have a genuinely strong culture—one that adapts well and brings people into it. It isn’t me; it’s others in the firm, but I think the EQT credit business was an excellent addition for Bridgepoint. The team remains fully intact. They’re running the broader credit platform. They truly feel like part of the furniture of the organization. Only about seven, eight months in, ECP feels exactly the same. I mean, tremendous people. We get along very well. They simply feel part of the leadership team. I think that says a lot about the people in this business and the openness and the culture of the organization. I’m confident we will find interesting businesses that want to join us and that will fit in culturally.
That's really useful. Appreciate it.
Alright. Is our friend off mute now? Duncan. Duncan.
Not at this point, though we do have a few questions coming in from the Zoom webinar. We’ll turn now to the questions that came in through the webcast page. At this point I’ll pass things to Adam Key, who will read the questions out. Lovely. Is there anything on the webcast page? Right. Should we allow Duncan one more minute? Nope. Okay. In that case?
He has already gotten his shot. The chance was his.
Great. Thanks so much, everyone. We’ll stop there.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Bridgepoint Group plc transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Bridgepoint Group plc earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.